奎寧市場規模、佔有率和成長分析：按產品類型、應用、劑型、原料、最終用戶、分銷管道和地區分類－2026-2033年產業預測

2024 年全球奎寧市場價值為 21 億美元，預計到 2025 年將成長至 22.2 億美元，到 2033 年將成長至 34.9 億美元，在預測期（2026-2033 年）內複合年成長率為 5.8%。

全球奎寧市場主要受抗瘧疾藥及其前驅治療需求的驅動，對供應鏈、定價和投資有顯著影響。該市場涵蓋金雞納樹皮、提取的奎寧鹽以及特色飲料調味劑，在維持瘧疾流行地區和飲料生產商的治療藥物供應方面發揮著至關重要的作用。從殖民時期的樹皮貿易發展到工業提取，該行業如今因一線抗瘧疾藥的日益增強而重新受到關注，醫療系統不得不依賴奎寧。此外，消費者對高檔雞尾酒和精釀湯力水的興趣日益濃厚，也推動了食品級奎寧的需求。這些不斷變化的市場環境為垂直整合的生產商帶來了機遇，同時也凸顯了高效供應鏈的重要性，以降低供不應求和氣候變遷的風險。

全球奎寧市場成長要素

瘧疾在流行地區的持續蔓延，以及對有效公共衛生措施的重新重視，推動了對現有抗瘧疾藥的需求，其中奎寧已成為重要的治療選擇。醫療專業人員和國家衛生政策強調穩定供應鏈和標準化給藥通訊協定的重要性，促進了持續的採購和生產工作。這種穩定的需求促使製藥公司維持產能並投資嚴格的品管措施，從而提高了市場穩定性，並確保奎寧在臨床和醫院環境中的持續供應。因此，這種有利的生態系統正在支撐全球奎寧市場的成長。

全球奎寧市場面臨的限制因素

由於奎寧已知的副作用和耐受性問題，全球奎寧市場面臨許多限制。這些擔憂導致醫療專業人員傾向於選擇更安全或耐受性更好的替代療法。對潛在副作用的擔憂會降低處方率，並導致負責公共採購的醫療機構猶豫不決。因此，這種謹慎的做法降低了安全至上的領域的需求，並迫使生產商和經銷商達到預期的銷售量和市場滲透率。這種不願推廣奎寧廣泛應用的做法阻礙了其充分發揮治療潛力。

全球奎寧市場趨勢

全球奎寧市場目前正經歷動態變化，其驅動力主要來自於製劑創新和特殊應用領域的湧現。製造商日益專注於開發新型製劑和標靶治療，以滿足細分市場的需求，從而催生出專業的給藥系統、聯合治療和多樣化的劑型。與臨床研究人員和藥房的合作策略正在重新評估產品定位，並在市場中創造高價值細分領域。監管獎勵推動了旨在滿足未被滿足的臨床需求的差異化產品的研發，而行銷策略也正轉向展示真實世界的效用並吸引醫療專業人士的參與。這延長了產品的生命週期，並幫助品牌獲得競爭優勢。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢
• 價格分析

全球奎寧市場規模：依產品類型分類

• 硫酸奎寧
• 鹽酸奎寧
• 鹽酸奎寧
• 其他

全球奎寧市場規模：按應用領域分類

• 製藥
  • 抗瘧疾藥
  • 瘧疾治療
  • 肌肉痙攣藥物
• 食品/飲料
  • 通寧水
  • 苦味
• 其他

全球奎寧市場規模：以劑型分類

• 粉末
• 液體
• 片劑/膠囊

全球奎寧市場規模：依來源分類

• 自然的
• 合成/半合成

全球奎寧市場規模：依最終用戶分類

• 醫院和診所
• 製藥公司
• 食品和飲料製造商
• 研究機構
• 其他

全球奎寧市場規模：按分銷管道分類

• 線上銷售
• 線下銷售

全球奎寧市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要企業2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要企業的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要企業簡介

• Bristol-Myers Squibb
• Bayer AG
• Sanofi
• Teva Pharmaceutical Industries Ltd.
• Mylan NV
• Hikma Pharmaceuticals PLC
• AstraZeneca
• GlaxoSmithKline
• Novartis AG
• Merck & Co., Inc.
• Johnson & Johnson
• Pfizer Inc.
• Eli Lilly and Company
• Amgen Inc.
• Gilead Sciences, Inc.
• Takeda Pharmaceutical Company Limited
• UCB SA
• Astellas Pharma Inc.
• Sumitomo Dainippon Pharma Co., Ltd.
• Daiichi Sankyo Company, Limited

結論與建議

Global Quinine Market size was valued at USD 2.1 Billion in 2024 and is poised to grow from USD 2.22 Billion in 2025 to USD 3.49 Billion by 2033, growing at a CAGR of 5.8% during the forecast period (2026-2033).

The global quinine market is primarily driven by its therapeutic demand as an antimalarial and pharmaceutical precursor, significantly impacting supply chains, pricing, and investment. This market encompasses cinchona bark, extracted quinine salts, and niche beverage flavoring, making it crucial for maintaining treatment availability in endemic regions and for beverage manufacturers. The sector's evolution from colonial bark trading to industrial extraction has led to its current resurgence due to increased resistance to first-line antimalarials, prompting health systems to rely on quinine. Moreover, heightened consumer interest in premium cocktails and artisanal tonics is spurring demand for food-grade quinine. This evolving landscape presents opportunities for vertically integrated producers and highlights the importance of efficient supply chains to mitigate risks linked to shortages and climate impacts.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Quinine market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Quinine Market Segments Analysis

Global quinine market is segmented by product type, application, form, by source, end user, distribution channel and region. Based on product type, the market is segmented into Quinine Sulfate, Quinine Hydrochloride, Quinine Dihydrochloride and Others. Based on application, the market is segmented into Pharmaceuticals, Food & Beverages and Others. Based on form, the market is segmented into Powder, Liquid and Tablets / Capsules. Based on by source, the market is segmented into Natural and Synthetic / Semi-Synthetic. Based on end user, the market is segmented into Hospitals & Clinics, Pharmaceutical Companies, Food & Beverage Manufacturers, Research Institutes and Others. Based on distribution channel, the market is segmented into Online Sales and Offline Sales. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Quinine Market

The ongoing prevalence of malaria in endemic regions, coupled with a renewed focus on effective public health interventions, has bolstered the demand for established antimalarials, with quinine emerging as a vital treatment option. Healthcare professionals and national health initiatives emphasize the importance of consistent supply chains and standardized dosing protocols, fostering ongoing procurement and manufacturing engagement. This steady demand encourages pharmaceutical companies to sustain their production capabilities and invest in rigorous quality control measures, thereby enhancing market stability and ensuring the continued accessibility of quinine within clinical and hospital environments. Consequently, this supportive ecosystem nurtures the growth of the global quinine market.

Restraints in the Global Quinine Market

The global quinine market faces significant restraints due to the known side effects and tolerability issues associated with the drug. These concerns often lead healthcare professionals to favor alternative treatments that may be perceived as safer or more tolerable. Such apprehensions regarding potential adverse reactions can result in reduced prescribing rates and hesitancy from healthcare programs in charge of public procurement. Consequently, this cautious mindset diminishes demand in segments that prioritize safety, putting pressure on manufacturers and distributors to achieve desired volumes and market penetration. As a result, the reluctance to adopt quinine more broadly hinders its therapeutic effectiveness from being fully realized.

Market Trends of the Global Quinine Market

The global quinine market is currently witnessing a dynamic shift driven by formulation innovation and the emergence of specialty uses. Manufacturers are increasingly focusing on developing novel formulations and targeted therapies that cater to niche markets, leading to the creation of specialized delivery systems, combination therapies, and diverse dosing formats. Collaborative strategies with clinical researchers and pharmacies are enhancing product repositioning, generating higher-value segmentation within the market. Regulatory incentives are favoring differentiated products aimed at addressing unmet clinical needs, prompting a shift in marketing strategies towards demonstrating real-world utility and engaging healthcare professionals, thus extending product lifecycles and positioning brands competitively.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape
• Pricing Analysis

Global Quinine Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Quinine Sulfate
• Quinine Hydrochloride
• Quinine Dihydrochloride
• Others

Global Quinine Market Size by Application & CAGR (2026-2033)

• Market Overview
• Pharmaceuticals
  • Antimalarial Drugs
  • Treatment of Malaria
  • Muscle Cramp Treatments
• Food & Beverages
  • Tonic Water
  • Bitter Flavoring Agents
• Others

Global Quinine Market Size by Form & CAGR (2026-2033)

• Market Overview
• Powder
• Liquid
• Tablets / Capsules

Global Quinine Market Size by Source & CAGR (2026-2033)

• Market Overview
• Natural
• Synthetic / Semi-Synthetic

Global Quinine Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals & Clinics
• Pharmaceutical Companies
• Food & Beverage Manufacturers
• Research Institutes
• Others

Global Quinine Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Online Sales
• Offline Sales

Global Quinine Market Size & CAGR (2026-2033)

• North America (Product Type, Application, Form, By Source, End User, Distribution Channel)
  • US
  • Canada
• Europe (Product Type, Application, Form, By Source, End User, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Application, Form, By Source, End User, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Application, Form, By Source, End User, Distribution Channel)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Application, Form, By Source, End User, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Bristol-Myers Squibb
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mylan N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hikma Pharmaceuticals PLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amgen Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gilead Sciences, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takeda Pharmaceutical Company Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• UCB S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Astellas Pharma Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sumitomo Dainippon Pharma Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Daiichi Sankyo Company, Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations